Ghrm1Btlr/Ghr+
C57BL/6J-Ghrm1Btlr
|
decreased body weight |
J:221475
|
Ghrm1Btlr/Ghrm1Btlr
C57BL/6J-Ghrm1Btlr
|
decreased body size |
J:221475
|
|
decreased body weight |
J:221475
|
Ghrtm1.1Dlr/Ghrtm1.1Dlr
Tg(Ins2-cre)23Herr/0
involves: 129S4/SvJae * C57BL/6J * CBA/J
|
decreased pancreatic beta cell mass |
J:284574
|
|
decreased pancreatic beta cell proliferation |
J:284574
|
|
decreased serotonin level |
J:284574
|
Ghrtm1.1Dlr/Ghrtm1.1Dlr
Tg(Ins2-cre)25Mgn/0
involves: 129S4/SvJae * C3H * C57BL/6 * DBA
|
decreased insulin secretion |
J:173909
|
|
decreased pancreatic beta cell mass |
J:173909
|
|
decreased pancreatic beta cell proliferation |
J:173909
|
|
increased circulating glucose level |
J:173909
|
Ghrtm1.1Jero/Ghr+
B6.129X1-Ghrtm1.1Jero
|
decreased body weight |
J:155335
|
Ghrtm1.1Jero/Ghrtm1.1Jero
B6.129X1-Ghrtm1.1Jero
|
decreased body weight |
J:155335
|
|
decreased circulating insulin-like growth factor I level |
J:155335
|
|
decreased epididymal fat pad weight |
J:155335
|
|
decreased inguinal fat pad weight |
J:155335
|
|
decreased length of long bones |
J:155335
|
|
decreased liver weight |
J:155335
|
|
increased brain weight |
J:155335
|
|
increased circulating growth hormone level |
J:155335
|
|
increased percent body fat/body weight |
J:155335
|
Ghrtm1.1Masp/Ghrtm1.1Masp
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
involves: 129S4/SvJaeSor * C57BL/6 * DBA
|
decreased bone mineral density |
J:152627
|
|
decreased circulating insulin-like growth factor I level |
J:152627
|
|
decreased circulating triglyceride level |
J:152627
|
|
decreased kidney weight |
J:152627
|
|
decreased liver triglyceride level |
J:152627
|
|
hepatic steatosis |
J:152627
|
|
impaired glucose tolerance |
J:152627
|
|
increased circulating free fatty acids level |
J:152627
|
|
increased circulating growth hormone level |
J:152627
|
|
increased circulating insulin level |
J:152627
|
|
increased liver weight |
J:152627
|
Ghrtm1.2Masp/Ghrtm1.2Masp
involves: 129S4/SvJaeSor
|
decreased body size |
J:152627
|
|
postnatal growth retardation |
J:152627
|
Ghrtm1Arge/Ghrtm1Arge
involves: 129S/SvEv * C57BL/6J
|
abnormal chondrocyte morphology |
J:66913
|
|
abnormal long bone epiphyseal plate proliferative zone |
J:66913
|
|
abnormal long bone hypertrophic chondrocyte zone |
J:66913
|
|
abnormal trabecular bone morphology |
J:66913
|
|
decreased circulating insulin-like growth factor I level |
J:66913
|
|
decreased litter size |
J:66913
|
|
decreased width of hypertrophic chondrocyte zone |
J:66913
|
|
delayed endochondral bone ossification |
J:66913
|
|
delayed sexual maturation |
J:66913
|
|
increased circulating growth hormone level |
J:66913
|
|
postnatal growth retardation |
J:66913
|
|
proportional dwarf |
J:66913
|
|
small kidney |
J:66913
|
|
small spleen |
J:66913
|
Ghrtm1c(KOMP)Wtsi/Ghrtm1c(KOMP)Wtsi
Tg(Fabp4-cre)1Rev/0
involves: C57BL/6N
|
abnormal fluid regulation |
J:206358
|
|
decreased circulating adiponectin level |
J:206358
|
|
decreased spleen weight |
J:206358
|
|
normal
homeostasis/metabolism phenotype |
J:206358
|
|
increased body weight |
J:206358
|
|
increased brown adipose tissue amount |
J:206358
|
|
increased circulating insulin-like growth factor I level |
J:206358
|
|
increased circulating interleukin-6 level |
J:206358
|
|
increased circulating leptin level |
J:206358
|
|
increased gonadal fat pad weight |
J:206358
|
|
increased kidney weight |
J:206358
|
|
increased lean body mass |
J:206358
|
|
increased mesenteric fat pad weight |
J:206358
|
|
increased retroperitoneal fat pad weight |
J:206358
|
|
increased soleus weight |
J:206358
|
|
increased subcutaneous adipose tissue amount |
J:206358
|
|
increased total body fat amount |
J:206358
|
|
increased white fat cell size |
J:206358
|
Ghrtm1Jjk/Ghr+
involves: 129P2/OlaHsd * BALB/c
|
decreased body length |
J:44604
|
|
postnatal growth retardation |
J:44604
|
Ghrtm1Jjk/Ghrtm1Jjk
involves: 129P2/OlaHsd
|
decreased body weight |
J:155335
|
|
decreased circulating insulin-like growth factor I level |
J:155335
|
|
decreased epididymal fat pad weight |
J:95149
|
|
decreased liver weight |
J:95149
|
|
increased brain weight |
J:95149
|
|
increased circulating growth hormone level |
J:155335
|
|
postnatal growth retardation |
J:95149
|
|
small kidney |
J:95149
|
Ghrtm1Jjk/Ghrtm1Jjk
involves: 129P2/OlaHsd * BALB/c
|
abnormal artery morphology |
J:157146
|
|
abnormal avoidance learning behavior |
J:96518
|
|
abnormal body weight |
J:63459
|
|
abnormal bone ossification |
J:60207
|
|
abnormal circulating lipid level |
J:105686
|
|
abnormal compact bone morphology |
J:60207
|
|
abnormal epididymis weight |
J:105921
|
|
abnormal food intake |
J:105686
|
|
abnormal learning/memory/conditioning |
J:96518
|
|
abnormal long bone epiphyseal plate morphology |
J:60207
|
|
abnormal metestrus |
J:79216
|
|
abnormal ovary physiology |
J:79216
|
|
abnormal seminal vesicle weight |
J:105921
|
|
abnormal skeleton development |
J:60207
|
|
abnormal spermatid morphology |
J:105921
|
|
abnormal spermatogenesis |
J:105921
|
|
abnormal testes secretion |
J:105921
|
|
decreased areal bone mineral density |
J:60207
|
|
decreased birth weight |
J:55142
|
|
decreased body length |
J:44604,
J:60207,
J:105686
|
|
decreased body size |
J:44604,
J:63459
|
|
decreased body weight |
J:53777,
J:63459,
J:105686,
J:105921,
J:110613,
J:132437
|
|
decreased bone mineral content |
J:60207,
J:105686
|
|
decreased brain weight |
J:132437
|
|
decreased circulating cholesterol level |
J:105686
|
|
decreased circulating estradiol level |
J:79216
|
|
decreased circulating glucose level |
J:105686,
J:110613
|
|
decreased circulating HDL cholesterol level |
J:105686
|
|
decreased circulating insulin level |
J:105686,
J:110613
|
|
decreased circulating insulin-like growth factor I level |
J:44604,
J:53777,
J:60207,
J:63459
|
|
decreased circulating LDL cholesterol level |
J:105686
|
|
decreased circulating luteinizing hormone level |
J:53777
|
|
decreased circulating testosterone level |
J:53777,
J:105921
|
|
decreased circulating triglyceride level |
J:105686
|
|
decreased circulating VLDL cholesterol level |
J:105686
|
|
decreased corpora lutea number |
J:79216
|
|
decreased epididymis weight |
J:105921
|
|
decreased fetal size |
J:55142
|
|
decreased fetal weight |
J:55142
|
|
decreased heart weight |
J:60207,
J:157146
|
|
decreased kidney weight |
J:60207,
J:132437
|
|
decreased lean body mass |
J:105686
|
|
decreased length of long bones |
J:60207
|
|
decreased litter size |
J:44604,
J:79216
|
|
decreased liver weight |
J:60207,
J:105686
|
|
decreased mature ovarian follicle number |
J:79216
|
|
decreased ovulation rate |
J:79216
|
|
decreased pituitary gland weight |
J:53777
|
|
decreased prostate gland ventral lobe weight |
J:53777
|
|
decreased seminal vesicle weight |
J:53777,
J:105921
|
|
decreased spleen weight |
J:60207
|
|
decreased susceptibility to autoimmune diabetes |
J:59132
|
|
decreased systemic arterial systolic blood pressure |
J:157146
|
|
decreased testes secretion |
J:53777
|
|
decreased testis weight |
J:53777,
J:60207,
J:105921
|
|
decreased triiodothyronine level |
J:60207
|
|
delayed balanopreputial separation |
J:105921
|
|
delayed female fertility |
J:44604
|
|
delayed male fertility |
J:79216
|
|
delayed sexual maturation |
J:55142,
J:105921
|
|
delayed vaginal opening |
J:55142
|
|
extended life span |
J:63459
|
|
female infertility |
J:79216
|
|
fetal growth retardation |
J:55142
|
|
impaired embryo implantation |
J:79216
|
|
impaired luteinization |
J:79216
|
|
impaired ovarian folliculogenesis |
J:79216
|
|
increased brain weight |
J:60207,
J:105686
|
|
increased circulating adiponectin level |
J:132437
|
|
increased circulating corticosterone level |
J:105686
|
|
increased circulating growth hormone level |
J:44604
|
|
increased circulating leptin level |
J:105686
|
|
increased circulating prolactin level |
J:53777
|
|
increased food intake |
J:105686
|
|
increased insulin sensitivity |
J:110613
|
|
increased interscapular fat pad weight |
J:105686
|
|
increased percent body fat/body weight |
J:105686,
J:132437
|
|
increased placenta weight |
J:55142
|
|
increased retroperitoneal fat pad weight |
J:105686,
J:132437
|
|
increased uterus weight |
J:55142
|
|
increased white adipose tissue amount |
J:132437
|
|
long gestation period |
J:55142
|
|
obese |
J:105686
|
|
perinatal lethality, incomplete penetrance |
J:44604,
J:55142
|
|
postnatal growth retardation |
J:44604,
J:63459
|
|
postnatal lethality, incomplete penetrance |
J:44604
|
|
prolonged diestrus |
J:79216
|
|
prolonged estrous cycle |
J:79216
|
|
proportional dwarf |
J:44604
|
|
reduced male fertility |
J:53777
|
|
short femur |
J:60207
|
|
short tibia |
J:60207
|
Ghrtm1Jjk/Ghrtm1Jjk
involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6
|
decreased activity of thyroid gland |
J:103286
|
|
decreased body temperature |
J:103286
|
|
decreased circulating glucose level |
J:103286
|
|
decreased circulating insulin level |
J:103286
|
|
decreased circulating thyroxine level |
J:103286
|
|
decreased circulating triiodothyronine level |
J:103286
|
|
increased circulating corticosterone level |
J:103286
|
Ghrtm1Jjk/Ghrtm1Jjk
involves: 129P2/OlaHsd * BALB/c * C57BL/6
|
abnormal blood homeostasis |
J:107763
|
|
decreased body weight |
J:107763
|
|
decreased circulating glucagon level |
J:107763
|
|
decreased circulating glucose level |
J:107763
|
|
decreased circulating insulin level |
J:107763
|
|
decreased circulating insulin-like growth factor I level |
J:107763
|
|
decreased liver weight |
J:107763
|
|
decreased pancreatic beta cell mass |
J:107763
|
|
hypoglycemia |
J:107763
|
|
increased abdominal fat pad weight |
J:107763
|
|
increased circulating chloride level |
J:107763
|
|
increased circulating creatine kinase level |
J:107763
|
|
increased circulating serum albumin level |
J:107763
|
|
increased insulin sensitivity |
J:107763
|
|
postnatal growth retardation |
J:107763
|
|
small pancreatic islets |
J:107763
|
Ghrtm1Mwat/Ghr+
involves: 129X1/SvJ * C57BL
|
postnatal growth retardation |
J:95149
|
Ghrtm1Mwat/Ghrtm1Mwat
involves: 129X1/SvJ * C57BL
|
decreased circulating insulin-like growth factor I level |
J:95149
|
|
hyperglycemia |
J:95149
|
|
increased brain weight |
J:95149
|
|
postnatal growth retardation |
J:95149
|
Ghrtm2Mwat/Ghr+
involves: 129X1/SvJ * C57BL
|
postnatal growth retardation |
J:95149
|
Ghrtm2Mwat/Ghrtm2Mwat
involves: 129X1/SvJ * C57BL
|
decreased circulating insulin-like growth factor I level |
J:95149
|
|
decreased liver weight |
J:95149
|
|
hyperglycemia |
J:95149
|
|
increased brain weight |
J:95149
|
|
increased total body fat amount |
J:95149
|
|
postnatal growth retardation |
J:95149
|
|
small kidney |
J:95149
|
|
small spleen |
J:95149
|
Excel File
Analysis Tools